{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:34Z","timestamp":1791218134612,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1053\/j.ajkd.2006.08.019","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T11:05:03Z","timestamp":1170759903000},"page":"761-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["J-Shaped Mortality Relationship for Uric Acid in CKD"],"prefix":"10.1053","volume":"48","author":[{"given":"Mohamed E.","family":"Suliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvia","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rashid","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Molinaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Heimb\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"B\u00e1r\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2006.08.019_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: Where are we now?","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.ajkd.2006.08.019_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid","volume":"8","author":"Sorensen","year":"1965","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2006.08.019_bib3","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2006.08.019_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.019_bib5","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2174\/138161205774913200","article-title":"Serum uric acid and risk of coronary heart disease","volume":"11","author":"Wannamethee","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"suppl F","key":"10.1053\/j.ajkd.2006.08.019_bib6","first-page":"S20F","article-title":"Uric acid in hypertension and cardiovascular disease","volume":"15","author":"Alderman","year":"1999","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.019_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","article-title":"Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus","volume":"29","author":"Lehto","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.ajkd.2006.08.019_bib9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.019_bib10","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","article-title":"Serum uric acid in relation to age and physique in health and in coronary heart disease","volume":"34","author":"Gertler","year":"1951","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.019_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00004872-199917070-00001","article-title":"Uric acid as a cardiovascular risk factor in arterial hypertension","volume":"17","author":"Puig","year":"1999","journal-title":"J Hypertens"},{"key":"10.1053\/j.ajkd.2006.08.019_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/oxfordjournals.aje.a117634","article-title":"Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome","volume":"142","author":"Lee","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199408183310709","article-title":"Inflammation and coronary artery disease","volume":"331","author":"Alexander","year":"1994","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1053\/j.ajkd.2006.08.019_bib14","first-page":"S41","article-title":"The oxidant stress hypothesis of atherogenesis","volume":"36","author":"Iuliano","year":"2001","journal-title":"Lipids"},{"key":"10.1053\/j.ajkd.2006.08.019_bib15","first-page":"645","article-title":"Serum uric acid and C-reactive protein levels in patients with chronic kidney disease","volume":"25","author":"Caravaca","year":"2005","journal-title":"Nefrologia"},{"key":"10.1053\/j.ajkd.2006.08.019_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2006.08.019_bib17","first-page":"448","article-title":"Renagel efficacy in severe secondary hyperparathyroidism","volume":"22","author":"Castro","year":"2002","journal-title":"Nefrologia"},{"key":"10.1053\/j.ajkd.2006.08.019_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ndt\/gfg563","article-title":"Serum uric acid levels show a \u2018J-shaped\u2019 association with all-cause mortality in haemodialysis patients","volume":"19","author":"Hsu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2006.08.019_bib19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.019_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0899-9007(03)00061-3","article-title":"Body composition interpretation","volume":"19","author":"Kyle","year":"2003","journal-title":"Nutrition"},{"key":"10.1053\/j.ajkd.2006.08.019_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ajcn\/40.4.808","article-title":"New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly","volume":"40","author":"Frisancho","year":"1984","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.ajkd.2006.08.019_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1681\/ASN.V641313","article-title":"Effect of chronic experimental renal insufficiency on urate metabolism","volume":"6","author":"Vaziri","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMoa021672","article-title":"Environmental lead exposure and progression of chronic renal diseases in patients without diabetes","volume":"348","author":"Lin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.019_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.019_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2188\/jea.10.403","article-title":"Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers","volume":"10","author":"Tomita","year":"2000","journal-title":"J Epidemiol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.24.691","article-title":"Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects","volume":"24","author":"Iseki","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1053\/j.ajkd.2006.08.019_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000045939","article-title":"Serum uric acid and renal prognosis in patients with IgA nephropathy","volume":"87","author":"Ohno","year":"2001","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2006.08.019_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ndt\/gfh584","article-title":"Uric acid correlates with the severity of histopathological parameters in IgA nephropathy","volume":"20","author":"Myllymaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2006.08.019_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/15.1.34","article-title":"Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy","volume":"15","author":"Syrjanen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2006.08.019_bib30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","article-title":"Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link?","volume":"16","author":"Johnson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000066303","article-title":"Hyperuricemia causes glomerular hypertrophy in the rat","volume":"23","author":"Nakagawa","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib32","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.019_bib34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.019_bib35","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Kang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats","volume":"67","author":"Sanchez-Lozada","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.019_bib37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/oxfordjournals.eurheartj.a015352","article-title":"Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure","volume":"18","author":"Leyva","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2006.08.019_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000150785.39055.e8","article-title":"Resurrection of uric acid as a causal risk factor in essential hypertension","volume":"45","author":"Johnson","year":"2005","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.019_bib39","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.019_bib41","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/jn\/125.8.2090","article-title":"Deprivation of dietary nucleotides results in a transient decrease in acid-soluble nucleotides and RNA concentration in rat liver","volume":"125","author":"Lopez-Navarro","year":"1995","journal-title":"J Nutr"},{"key":"10.1053\/j.ajkd.2006.08.019_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2005.05.009","article-title":"Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: Implications for uncoupling endothelial nitric oxide synthase","volume":"70","author":"Kuzkaya","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","article-title":"Effect of insulin on renal sodium and uric acid handling in essential hypertension","volume":"9","author":"Muscelli","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1053\/j.ajkd.2006.08.019_bib44","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/euhj.1998.1188","article-title":"Uric acid in chronic heart failure: A marker of chronic inflammation","volume":"19","author":"Leyva","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2006.08.019_bib45","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2005090949","article-title":"Uric acid and endothelial dysfunction in essential hypertension","volume":"17","author":"Zoccali","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","article-title":"Inflammation in end-stage renal disease: The hidden enemy","volume":"11","author":"Stenvinkel","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.ajkd.2006.08.019_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1054\/mehy.2000.1272","article-title":"Hypophosphataemia: Cause of the disturbed metabolism in the metabolic syndrome","volume":"56","author":"Haglin","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1053\/j.ajkd.2006.08.019_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2005.01.005","article-title":"Disturbances of phosphate metabolism: Another feature of metabolic syndrome","volume":"45","author":"Kalaitzidis","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.019_bib49","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1253\/circj.69.928","article-title":"Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome","volume":"69","author":"Yoo","year":"2005","journal-title":"Circ J"},{"key":"10.1053\/j.ajkd.2006.08.019_bib50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1515\/JPEM.2003.16.9.1225","article-title":"Serum uric acid levels in obese children and adolescents: Linkage to testosterone levels and pre-metabolic syndrome","volume":"16","author":"Denzer","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2006.08.019_bib51","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.1991.287","article-title":"Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism","volume":"40","author":"Hsu","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.019_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.V441035","article-title":"Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure","volume":"4","author":"Vanholder","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.019_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0026-0495(98)90267-0","article-title":"Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout","volume":"47","author":"Takahashi","year":"1998","journal-title":"Metabolism"},{"key":"10.1053\/j.ajkd.2006.08.019_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.0000085858.66548.59","article-title":"Hyperuricemia in childhood primary hypertension","volume":"42","author":"Feig","year":"2003","journal-title":"Hypertension"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638606013564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638606013564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:46:06Z","timestamp":1759455966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638606013564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0272638606013564"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2006.08.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"J-Shaped Mortality Relationship for Uric Acid in CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2006.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}